Key statistics
As of last trade Context Therapeutics Inc (CNTX:NAQ) traded at 2.38, -16.49% below its 52-week high of 2.85, set on Jan 30, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 2.25 |
|---|---|
| High | 2.38 |
| Low | 2.16 |
| Bid | 2.37 |
| Offer | 2.38 |
| Previous close | 2.29 |
| Average volume | 622.97k |
|---|---|
| Shares outstanding | 91.88m |
| Free float | 90.79m |
| P/E (TTM) | -- |
| Market cap | 210.40m USD |
| EPS (TTM) | -0.2835 USD |
Data delayed at least 15 minutes, as of Mar 03 2026 18:23 GMT.
More ▼
- Context Therapeutics to Participate in Upcoming Investor Conferences
- Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Context Therapeutics Highlights CT-95 and CT-202 Programs at 2025 SITC Annual Meeting
- Context Therapeutics Reports Third Quarter 2025 Operating and Financial Results
- Context Therapeutics to Participate in Upcoming Investor Conferences
- Context Therapeutics Announces Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
- Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Context Therapeutics to Participate in Upcoming Investor Conferences
- Context Therapeutics Reports Second Quarter 2025 Operating and Financial Results
- Context Therapeutics Announces CTIM-76 Trial in Progress Poster Presentation at 2025 ASCO Meeting
More ▼
